Centrus Energy Corp. (LEU) Stock Price & How to Invest

Last updated November 2026

Short answer

You can invest in Centrus Energy (LEU) by buying shares or fractional shares at any major broker, through an ETF that holds it, or as one holding in a thematic basket. Centrus is a US nuclear-fuel company that supplies enriched uranium to power-plant operators and runs the only US-licensed HALEU enrichment facility, in Piketon, Ohio, producing the high-assay low-enriched uranium that advanced reactors need. The thesis is that US efforts to reshore enrichment and the ban on Russian uranium imports give Centrus a policy-backed runway to expand domestic capacity. The biggest risks are heavy dependence on government funding and contracts, customer concentration, swings in enrichment (SWU) prices, and the execution risk of scaling up a capital-intensive plant. The stock has been extremely volatile: as of October 16, 2026 it closed near $118.79, down about 56% year to date and about 71% over one year, for a market value of roughly $2.4 billion.

LEU stock price

As of 2026-11-16, Centrus Energy Corp. (LEU) last closed at $97.53, down 60.3% over the past year. Over the past 52 weeks it has traded between $89.03 and $337.76.

LEU last close
$97.53
1 day
-6.02%
1 month
-15.15%
1 year
-60.30%
52-week range
$89.03 to $337.76
Last close
2026-11-16

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Centrus Energy Corp.'s investor relations page. Walnut is informational, not investment advice.

LEU key stats

At $97.53 on November 16, 2026, Centrus Energy Corp. (LEU) has a market cap of $2.0B and a P/E of 28.9 on trailing earnings (23.3 on forward earnings).

Market cap
$2.0B
P/E (trailing)
28.9
P/E (forward)
23.3
EPS (trailing 12 months)
$3.37
Price to book
1.8
Beta
1.41

Market cap, P/E and yield are measured at the $97.53 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Centrus Energy Corp. (LEU)?

The last two weeks for Centrus Energy Corp., as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • LEU closed at $97.53 on November 16, 2026, down 16.9% over the past five trading days (from $117.34).
  • On November 12, 2026, Centrus Energy Corp. filed an 8-K with the SEC reporting other events (Item 8.01). Read the 8-K on sec.gov
  • On November 10, 2026, Centrus Energy Corp. filed an 8-K with the SEC reporting a change in its directors or officers (Item 5.02). Read the 8-K on sec.gov
  • On November 5, 2026, Centrus Energy Corp. filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
  • On November 4, 2026, Centrus Energy Corp. filed an 8-K with the SEC reporting quarterly results (Item 2.02). Read the 8-K on sec.gov
  • On November 7, 2026, JP Morgan lowered its target to $100.00 from $120.00 (Neutral).
  • On November 6, 2026, Barclays lowered its target to $149.00 from $150.00 (Equal-Weight).
  • On November 6, 2026, Roth Capital kept its Buy rating and $115.00 target.

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Centrus Energy Corp. (LEU) latest quarter

Centrus Energy reported revenue of $55.5 million for Q3 2026, down 26% from a year earlier (Centrus Energy, Nov 4, 2026).

Revenue
$55.5 million
down 26% from a year earlier
Diluted EPS (GAAP)
$1.41
up 642% from a year earlier
LEU
$31.8 million
down 29% from a year earlier

Source: Centrus Energy Q3 2026 results, Nov 4, 2026. Full earnings breakdown

What does Centrus Energy Corp. (LEU) do?

Centrus Energy, headquartered in Bethesda, Maryland, supplies nuclear fuel and fuel-cycle services to the commercial power industry. It operates through two segments. The Low-Enriched Uranium (LEU) segment buys separative work units (SWU) and uranium and sells enriched uranium to utilities that run nuclear reactors, a business carried by long-term contracts and a large multi-year order backlog. The Technical Solutions segment houses the company's American Centrifuge work, including its US-government HALEU enrichment contract, contract engineering, and technical services, and is the platform Centrus is using to build new domestic enrichment capacity.

Centrus traces its roots to the former US Enrichment Corporation, the government enrichment enterprise that was privatized, and it emerged from a 2014 bankruptcy reorganization refocused on its own centrifuge technology. Its strategic turn came as Washington moved to rebuild a domestic nuclear-fuel supply chain: Congress passed the Prohibiting Russian Uranium Imports Act in 2024, which banned most Russian enriched-uranium imports and unlocked about $2.7 billion in federal funding for US enrichment. Centrus runs the only US-licensed HALEU facility, delivered its first HALEU to the Department of Energy, and in early 2026 was selected for a roughly $900 million DOE task order to add commercial-scale HALEU and expand enrichment at Piketon, Ohio. In 2026 it also signed a multi-year HALEU supply agreement with advanced-reactor developer Antares Nuclear, and its LEU and HALEU order backlog reached about $4.5 billion at the end of the second quarter. That Russian-import-ban tailwind plus growing demand for HALEU from advanced-reactor developers is the core of the investment story, though the share price has fallen hard in 2026 as nuclear stocks sold off and investors weighed how long the backlog will take to turn into earnings.

What's driving Centrus Energy Corp. (LEU)?

1. HALEU and the DOE expansion award.

Centrus runs the only US-licensed HALEU enrichment plant and has delivered HALEU to the Department of Energy, including a 900-kilogram milestone delivery in 2025. In early 2026 it was selected for a roughly $900 million DOE task order, which could exceed $1 billion with options, to build commercial-scale HALEU and expand enrichment at Piketon, Ohio. The base build-out targets about 12 metric tons of HALEU capacity per year with a first cascade aimed to come online around 2029, positioning Centrus as a domestic supplier for advanced reactors. A multi-year HALEU supply agreement with Antares Nuclear, reported in October 2026, adds a commercial customer for that future output.

2. Russian-import-ban tailwind and reshoring.

The Prohibiting Russian Uranium Imports Act, effective in 2024, banned most Russian enriched-uranium imports, which had supplied around a quarter of US reactor demand, and unlocked about $2.7 billion in federal funding for US enrichment. Russia retaliated with its own export restrictions. As one of the few Western enrichers, Centrus benefits from utilities and the government seeking non-Russian supply, which underpins its LEU contracting and its case for new capacity.

3. Long-term LEU backlog and contracting.

Centrus ended 2025 with a total company backlog of about $3.8 billion extending to 2040, and by the end of the second quarter of 2026 its LEU and HALEU order backlog had grown to about $4.5 billion, roughly 9.5 times projected 2026 revenue. Much of that converts to revenue in the late 2020s and 2030s, so the backlog gives visibility but not near-term growth: consensus expects 2026 revenue of about $473 million and 2027 revenue of about $476 million, close to the 2025 level.

4. Balance sheet and capacity to invest.

Centrus held about $1.87 billion in cash at mid-2026 against about $1.18 billion of debt, mostly convertible notes raised in late 2024 and 2025 to fund growth. Trailing free cash flow was about -$127 million as spending on the expansion ramps up. That cash cushion gives it room to scale, though large capital projects also carry execution and dilution risk, and rising capital spending is expected to weigh on near-term earnings.

What are the risks to Centrus Energy Corp. (LEU)?

Centrus is heavily dependent on government funding and contracts: its HALEU program runs on DOE awards and extensions, and a multi-billion-dollar expansion relies on continued federal support and appropriations that can shift with politics. Customer concentration is high, with a limited set of utilities and the US government driving revenue, so the loss or delay of a single contract can swing results. Quarterly results are lumpy: the third quarter of 2026 (report expected around November 4) carries a consensus EPS of only about $0.01 on revenue of about $65 million, after a strong second quarter. The business is exposed to enrichment (SWU) and uranium price cycles, which are volatile and can compress margins. Scaling up centrifuge cascades is capital-intensive and technically demanding, raising execution and timeline risk, and the company faces competition from larger global enrichers and from other US funding recipients. Sentiment risk is real: the stock is down about 71% over one year as nuclear and uranium names sold off together, and it still trades at about 55x trailing and 31x forward earnings, leaving it sensitive to any disappointment.

What is the Centrus Energy Corp. (LEU) forecast?

19 analysts publish price targets on LEU, averaging $194.09 as of November 2026, or +99.0% against the $97.53 share price on November 16, 2026. The published targets run from $100.00 to $337.00, a wide spread, and the ratings split 13 buy, 7 hold, 0 sell. Over the last six months there have been 0 raises and 8 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full LEU forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

Is LEU a buy or a sell?

We give no verdict on Centrus Energy Corp.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. HALEU and the DOE expansion award. Centrus runs the only US-licensed HALEU enrichment plant and has delivered HALEU to the Department of Energy, including a 900-kilogram milestone delivery in 2025. The most optimistic published target, $337.00, assumes this works close to its best case.

The case against. Centrus is heavily dependent on government funding and contracts: its HALEU program runs on DOE awards and extensions, and a multi-billion-dollar expansion relies on continued federal support and appropriations that can shift with politics. The most pessimistic target, $100.00, is roughly what LEU is worth if this bites instead.

Read the full bull and bear case on LEU, including what would have to change to break either one. Walnut is not an investment adviser.

Has Centrus Energy Corp. (LEU) split its stock?

No. Centrus Energy Corp. (LEU) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

How is Centrus Energy Corp. (LEU) valued?

Market cap, P/E and dividend yield at today's price are in the LEU key stats above. The business figures below come from Centrus Energy Corp.'s reported results as of October 2026 and change when it next reports.

  • Revenue (TTM): ~$474 million (latest quarter +14% YoY)
  • Net income (TTM): ~$48.5 million (EPS ~$2.14)
  • Gross / operating margin: ~24% / ~5%
  • Backlog: ~$4.5 billion LEU and HALEU (end of Q2 2026)
  • Cash / debt: ~$1.87 billion cash, ~$1.18 billion debt

As of October 2026: A nuclear-fuel company like Centrus is read differently from a typical industrial: the multi-year backlog and contract structure matter more than any single quarter, because LEU revenue is lumpy and recognized as deliveries occur. After a roughly 71% fall in a year, Centrus's market value of about $2.4 billion sits only modestly above its cash pile, yet the earnings multiple is still high (about 55x trailing) because profits are small relative to the expansion story. Analysts' mean target is about $241 with a buy consensus, a wide gap to the price that mirrors how differently investors judge the timing of the HALEU build-out. All figures are approximate as of October 16, 2026; verify against Centrus's investor relations page or your broker.

Which ETFs hold Centrus Energy Corp. (LEU)?

If you want LEU exposure as part of a larger bundle, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

ETFName% in LEUExpense ratio
URAGlobal X Uranium ETF2.7%0.69%

Who competes with Centrus Energy Corp. (LEU)?

Uranium enrichers and fuel suppliers

Centrus competes in enrichment with large global players, most of which are state-linked or privately held: Urenco (a European consortium), Orano (France, which also received US HALEU funding), and Russia's Rosatom/Tenex, historically the dominant low-cost supplier now largely shut out of the US. Other US funding recipients such as General Matter and Global Laser Enrichment are emerging rivals for domestic enrichment capacity. Most of these are not directly investable as US-listed stocks, which is part of Centrus's scarcity appeal.

Uranium miners

Centrus enriches uranium rather than mining it, but investors often compare it with miners that supply the front of the fuel cycle. Cameco (CCJ) is the largest publicly traded Western uranium miner, and Kazatomprom (Kazakhstan) is the world's biggest producer. These names give exposure to uranium prices and nuclear demand but with a different business model than enrichment.

ETFs and nuclear-fuel alternatives

Investors who want diversified exposure to the nuclear and uranium theme rather than a single enricher often use ETFs such as the Global X Uranium ETF (URA), the Sprott Uranium Miners ETF (URNM), and the VanEck Uranium and Nuclear ETF (NLR). These funds hold baskets of miners, enrichers, utilities, and reactor builders, and some include Centrus at a small weight; check current holdings with the provider.

What stocks are similar to Centrus Energy Corp. (LEU)?

Other names that sit close to LEU: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

How to invest in Centrus Energy Corp. (LEU)

There are three common ways to get LEU exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (URA), which spreads the position across many companies. Or build it into a focused thematic portfolio, so LEU sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where LEU fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

The bottom line on Centrus Energy Corp. (LEU)

If you believe the US will keep reshoring uranium enrichment away from Russia and that Centrus can scale its Piketon plant to serve both existing reactors and the next generation of advanced reactors that run on HALEU, then Centrus Energy (LEU) is a focused way to express that view. It is a volatile, policy-driven growth stock whose price swings sharply with DOE funding news, contract awards, enrichment prices, and the nuclear-sentiment cycle. 2026 has shown that side of it: shares have fallen from a 52-week high above $400 to under $120 even as the backlog grew to about $4.5 billion, so most holders treat it as a high-volatility position sized inside a basket.

More on Centrus Energy Corp. (LEU)

Whether LEU is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is LEU a buy or a sell?, and where the stock could go from here in the LEU stock forecast.

For income investors, whether LEU pays a dividend and how the payout looks is covered in does LEU pay a dividend? And to weigh LEU against a peer, read the full side-by-side comparisons: LEU vs CCJ and LEU vs NXE.

Wondering how LEU fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Centrus Energy Corp.

Ask Walnut's AI anything about LEU and see how it fits what you own.

FAQ

What does Centrus Energy do?

+

Centrus Energy supplies nuclear fuel and fuel-cycle services. Its Low-Enriched Uranium segment sells enriched uranium to utilities that run nuclear reactors under long-term contracts, and its Technical Solutions segment houses its American Centrifuge work, including a US-government HALEU enrichment contract and engineering services. Centrus runs the only US-licensed HALEU enrichment facility, in Piketon, Ohio, producing the high-assay fuel that advanced reactors need.

What is LEU's ticker symbol and where is it listed?

+

The company trades as LEU on the NYSE American exchange, officially Centrus Energy Corp., headquartered in Bethesda, Maryland. The ticker comes from low-enriched uranium, its core product. It is available at every major US brokerage with commission-free trading, and many brokers also offer fractional shares so you can invest a fixed dollar amount.

Does LEU pay a dividend?

+

No. Centrus Energy does not currently pay a dividend on its common stock, so its yield is 0%. The company is reinvesting in expanding US enrichment capacity rather than returning cash to shareholders, so any return would come from share-price changes rather than dividend income. The figure is current as of October 2026; verify against Centrus's investor relations page.

What is HALEU and why does it matter?

+

HALEU stands for high-assay low-enriched uranium, fuel enriched to between 5% and 20% uranium-235, higher than the roughly 5% used in today's reactors. Many next-generation advanced and small modular reactors are designed to run on it, but there has been almost no commercial Western supply. Centrus runs the only US-licensed HALEU facility and has delivered HALEU to the Department of Energy, which is central to its growth story.

How does the Russian uranium import ban help Centrus?

+

The Prohibiting Russian Uranium Imports Act, effective in 2024, banned most Russian enriched-uranium imports, which had supplied around a quarter of US reactor demand, and unlocked about $2.7 billion in federal funding for domestic enrichment. As one of the few Western enrichers, Centrus benefits from utilities and the government seeking non-Russian supply, supporting its LEU contracting and its case for building new US capacity.

How did Centrus do in its latest quarter?

+

In the second quarter of 2026 (ended June 30), Centrus reported revenue of about $176 million, up about 14% year over year, and net income of about $16.8 million. EPS of $1.77 came in well above the roughly $0.81 consensus, the second straight beat after $1.05 versus $0.27 in the first quarter. The next report is expected around November 4, 2026, with a consensus of about $0.01 EPS on revenue of about $65 million, because lumpy delivery timing moves quarterly results around.

How has LEU stock performed in 2026?

+

Badly, after a huge 2025. As of the October 16, 2026 close of about $118.79, LEU was down about 56% year to date and about 71% over one year, near the bottom of a 52-week range of roughly $113 to $412. The decline came alongside a sell-off across uranium and reactor stocks and despite earnings beats, as investors focused on how long the backlog takes to convert and on rising capital spending.

Is LEU a good stock?

+

This is descriptive, not advice. The bull case is that Centrus is the leading US-listed enricher with the only US-licensed HALEU plant, a large DOE award, a backlog of about $4.5 billion, and a strong policy tailwind from the Russian-import ban. The bear case is heavy dependence on government funding and contracts, customer concentration, volatile enrichment prices, costly scale-up execution, and a still-high earnings multiple even after the 2026 decline. Whether it fits depends on your own goals and risk tolerance.

Is LEU a good stock to buy right now?

+

This is informational, not a recommendation. Centrus was one of the strongest-performing nuclear-fuel stocks in 2025, driven by DOE HALEU awards and the reshoring of enrichment, but it has fallen about 56% in 2026 and remains volatile, swinging sharply on policy and contract news. Analysts' consensus rating is buy with a mean target near $241, and Guggenheim initiated coverage at buy with a $167 target in October 2026, but targets are opinions, not forecasts you can rely on. Timing depends on your own goals, time horizon, and risk tolerance, and past performance does not predict future returns. Walnut provides information, not investment advice.

Which ETFs or baskets include LEU?

+

Centrus appears in uranium and nuclear-energy ETFs such as the Global X Uranium ETF (URA), the Sprott Uranium Miners ETF (URNM), and the VanEck Uranium and Nuclear ETF (NLR), typically at a small weight, and in small-cap index funds. Holdings shift as funds rebalance, so check a fund's current holdings with its provider. In Walnut you can also hold LEU as one constituent of a thematic nuclear or energy basket.

Guides that feature LEU

LEU is one of the names covered in these guides. Each one puts the stock next to its peers so you can see where it fits rather than judging it alone.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Centrus Energy Corp.'s investor relations page or your broker before making investment decisions.